| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/15/2006 | US20060128703 crystalline linezolid form III (N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide) an antibacterial agent; thermal stability |
| 06/15/2006 | US20060128702 Heterocyclic and bicyclic compounds, compositions and methods |
| 06/15/2006 | US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists |
| 06/15/2006 | US20060128689 N-(7-tert-butyl-3,4-dihydro-2H-chromen-4-yl)-N'-1H-indazol-4-ylurea, used to treat or prevent pain, inflammatory thermal hyperalgesia, bladder overactivity and urinary incontinence |
| 06/15/2006 | US20060128687 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/15/2006 | US20060128685 Pyrazole derivative |
| 06/15/2006 | US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms |
| 06/15/2006 | US20060128642 Pesticides, controlling animal pests |
| 06/15/2006 | US20060128568 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazoles and their use as herbicides |
| 06/15/2006 | US20060124014 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
| 06/15/2006 | CA2594102A1 Pyrazine dicarboxamides and the use thereof |
| 06/15/2006 | CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/15/2006 | CA2590115A1 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 06/15/2006 | CA2589274A1 Inhibitors of protein kinases |
| 06/15/2006 | CA2589271A1 Urea inhibitors of map kinases |
| 06/15/2006 | CA2587559A1 Aryloxyethylamine derivatives with a combination of partial d0pamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | CA2587381A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | CA2587202A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | CA2586991A1 Substituted indoles, compositions containing them, method for the production thereof and their use |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1668162A1 Detection of immobilized nucleic acid |
| 06/14/2006 | EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors |
| 06/14/2006 | EP1668006A1 Quinazoline derivatives as antiproliferative agents |
| 06/14/2006 | EP1668005A1 Acyloxymethylcarbamate prodrugs of oxazolidinones |
| 06/14/2006 | EP1668004A1 Benzoxazole acetonitriles |
| 06/14/2006 | EP1668003A1 Benzisoxazoles |
| 06/14/2006 | EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof |
| 06/14/2006 | EP1667995A1 Benzimidazole acetonitriles |
| 06/14/2006 | EP1667994A1 Quinolone antibacterial agents |
| 06/14/2006 | EP1667993A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 06/14/2006 | EP1667990A2 New compounds |
| 06/14/2006 | EP1667980A1 1,4-disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 06/14/2006 | EP1667973A2 Quinoline potassium channel inhibitors |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1578746B1 Oxazoles as mglur1 enhancer |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP0966283B1 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells |
| 06/14/2006 | CN1788008A 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787997A 4-arylsulphonylpiperidine derivatives for antagonism of the 5-HT2A receptor |
| 06/14/2006 | CN1787822A Compouds and uses thereof in modulating amyloid beta |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/13/2006 | USRE39127 Heterocyclic compounds |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060822 2-pyrazolin-5-ones |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
| 06/13/2006 | US7060710 Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligands |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060698 5-alkylaminocarbonyl-substituted, e.g., 4-(1-benzyl-piperidin-4-yl)-2-isopropyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepine-5-carboxylic acid tert-butylamide; gamma -secretase inhibitors for the treatment of Alzheimer's disease. |
| 06/13/2006 | CA2387997C Process for preparing oxazolines from tetrahydrofurans |
| 06/13/2006 | CA2268954C Oxadiazoles, processes for their preparation and their use as medicaments |
| 06/13/2006 | CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same |
| 06/13/2006 | CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives |
| 06/08/2006 | WO2006060730A2 Potassium salt of an hiv integrase inhibitor |
| 06/08/2006 | WO2006060712A2 Potassium salt of an hiv integrase inhibitor |
| 06/08/2006 | WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | WO2006059945A1 Novel compounds |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 06/08/2006 | WO2006059234A2 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | WO2006058630A1 Cyclic iminocarbamates and use thereof |
| 06/08/2006 | WO2006044602A9 Diphenyl substituted alkanes as flap inhiibitors |
| 06/08/2006 | WO2006011024A9 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 06/08/2006 | WO2005107464A3 Compounds and compositions as cathepsin s inhibitors |
| 06/08/2006 | US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems |
| 06/08/2006 | US20060122432 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol |
| 06/08/2006 | US20060122399 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 06/08/2006 | US20060122397 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor; neurological disorders, psychiatric disorders, acute and chronic pain |
| 06/08/2006 | US20060122388 Thiocarbamate inhibitors of alpha-4 integrins |
| 06/08/2006 | US20060122387 Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
| 06/08/2006 | US20060122386 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators |
| 06/08/2006 | US20060122259 Immobilization of taxane; anticancer, antitumor agents |
| 06/08/2006 | US20060122247 Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| 06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122207 Imidazol derivatives as Raf kinase inhibitors |
| 06/08/2006 | US20060122205 Potassium salt of an HIV integrase inhibitor |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 06/08/2006 | US20060122190 Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| 06/08/2006 | US20060122189 Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| 06/08/2006 | US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/08/2006 | US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 06/08/2006 | US20060122177 Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 06/08/2006 | US20060122175 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 06/08/2006 | US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |
| 06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 06/08/2006 | US20060122063 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
| 06/08/2006 | DE102004058062A1 Cyclische Iminocarbamate und ihre Verwendung Cyclic Iminocarbamate and their use |